Cluster Headache Treatment With Rimegepant-Open Label Pilot Study
Latest Information Update: 24 Jan 2025
At a glance
- Drugs Rimegepant (Primary)
- Indications Cluster headache
- Focus Therapeutic Use
Most Recent Events
- 22 Jan 2025 Status changed from recruiting to active, no longer recruiting.
- 13 Jan 2025 Planned End Date changed from 1 Dec 2024 to 1 Dec 2025.
- 13 Jan 2025 Planned primary completion date changed from 1 Dec 2024 to 1 Dec 2025.